Daily Sepsis Research Analysis
Analyzed 32 papers and selected 3 impactful papers.
Summary
Today's top sepsis research spans prevention, diagnosis, and pathophysiology. A Nature Communications study shows phage-steering plus vaccination prevents gut colonization and vertical transmission of E. coli K1, a major neonatal sepsis pathogen. A translational transcriptomics study links neutrophil programs in sterile vasoplegic syndrome to a septic shock subtype, while a proteomics-to-point-of-care study presents a urinary thrombomodulin strip for rapid sepsis screening and shock risk prediction.
Research Themes
- Microbiome and phage-engineering strategies for neonatal sepsis prevention
- Non-invasive diagnostics and risk stratification tools for sepsis
- Shared innate immune programs across sterile and infectious shock states
Selected Articles
1. Phage-steering permits antibody-mediated clearance of E. coli K1 from the gut.
In mice, K1-specific phages select capsule-deficient E. coli mutants that expose O-antigen, rendering them vulnerable to vaccine-induced intestinal IgA and enabling competitive exclusion by E. coli Nissle. Maternal vaccination plus phage therapy protected 77% of pups from E. coli K1 transmission, outperforming either modality alone.
Impact: Introduces a generalizable phage-steering concept that couples microbial evolution with mucosal vaccination to eliminate a neonatal sepsis reservoir. High translational potential for maternal–infant prevention strategies.
Clinical Implications: If translated to humans, maternal vaccination plus phage-steering could reduce E. coli K1 gut colonization and vertical transmission, potentially preventing neonatal sepsis and meningitis without broad-spectrum antibiotics.
Key Findings
- K1-specific phages drove rapid selection of capsule-less E. coli mutants with exposed O-antigens.
- Vaccine-induced intestinal IgA targeted O-antigen, enabling competitive exclusion by E. coli Nissle.
- Maternal vaccination plus phages protected 77% of pups from E. coli K1 transmission; either alone was inferior.
Methodological Strengths
- Murine vertical transmission model integrating phage therapy, vaccination, and probiotic competition.
- Mechanistic demonstration of within-host evolutionary steering (capsule loss) to expose immune targets.
Limitations
- Preclinical murine study; human efficacy and safety are untested.
- High E. coli diversity may limit generalizability across strains and hosts.
Future Directions: Evaluate safety, dosing, and efficacy of combined maternal vaccination and phage therapy in translational models and early-phase human studies; define strain coverage and resistance dynamics.
Escherichia coli (E. coli) strains expressing the capsule serotype K1 (E. coli K1) are a prevalent cause of neonatal sepsis and meningitis. The gut microbiota of healthy adults is a natural reservoir of E. coli K1, from which it can spread to extra-intestinal sites or be transmitted from mother to infant during birth. Accordingly, shifting gut colonization from potentially pathogenic E. coli strains to more benign strains could reduce the risk of disease. Here, we leverage selective pressures exerted by bacteriophage and mucosal antibodies to limit gut colonization by E. coli K1 and prevent its transmission. K1-specific bacteriophages (phages) rapidly drive a within-host evolution of capsule-less mutants with exposed surface O-antigens. These mutants become susceptible to vaccine-induced intestinal IgA targeting the bacterial O-antigen, allowing competitive exclusion by the probiotic strain E. coli Nissle. In a murine vertical transmission model, 77% of pups were protected from transmission of E. coli K1 when the mother was vaccinated and treated with phages, whereas E. coli K1 was detected in most pups by day 10 of life when the mother received vaccination or phage therapy alone. Although the high diversity of E. coli makes generalization challenging, combining vaccination with phage-steering represents a promising approach for further exploration in eliminating infectious reservoirs.
2. Neutrophil Transcriptomic Changes in Severe Sterile Vasoplegic Syndrome Resemble a Distinct Molecular Subtype of Septic Shock.
Two distinct neutrophil transcriptomic phenotypes emerged in severe vasoplegic syndrome, one of which mirrored a septic shock-like program with elevated MMP8 mRNA. Findings suggest a shared neutrophil molecular program underpinning multi-organ failure across sterile and septic inflammation.
Impact: Bridges sterile postoperative vasoplegia and septic shock at the neutrophil transcriptomic level, nominating potential shared targets (e.g., MMP8) for immunomodulatory strategies.
Clinical Implications: Supports biomarker-driven stratification and potential repurposing of immunomodulators targeting neutrophil programs across sterile and infectious shock phenotypes.
Key Findings
- Identified two consistent neutrophil transcriptomic phenotypes in vasoplegic syndrome.
- Severe vasoplegia showed a dynamic program resembling septic shock with elevated MMP8 mRNA.
- Core surgical response genes were separable from shock-associated neutrophil programs.
Methodological Strengths
- Longitudinal neutrophil transcriptomics correlated with clinical and cytokine profiles.
- Comparative framework including surgical controls and septic shock reference datasets.
Limitations
- Observational design with potential confounding and batch effects across datasets.
- Sample sizes and external generalizability are not detailed in the abstract.
Future Directions: Validate MMP8-high neutrophil phenotypes prospectively, test targetability in preclinical models, and assess predictive value for organ failure and therapy response.
BACKGROUND: Understanding early molecular events in systemic inflammation in sepsis is complicated by host-pathogen interactions and responses over time. Vasoplegic syndrome after cardiac surgery resembles septic shock but lacks pathogen-related variables and proceeds over a defined, reproducible time course. We hypothesized that human neutrophil transcriptomic changes in vasoplegic syndrome would resemble one or more molecular subtypes of septic shock. METHODS: We compared dynamic human neutrophil transcriptomic changes during development of vasoplegic syndrome to 1) dynamic changes in uncomplicated cardiac surgery and 2) static transcriptomic profiles in septic shock. Vasoplegic syndrome was defined as vasopressor requirement to maintain MAP >60 mmHg, CI >2.2 L min -1 m -2, and systemic vascular resistance index < 1970 d s cm -5 m 2 lasting at least 24 hours postoperatively. Septic shock was defined as acute refractory organ dysfunction due to infection. Neutrophil transcriptomics were correlated with clinical course and plasma cytokine levels. RESULTS: In principal component analysis, neutrophil transcriptomes from surgical patients demonstrated core gene expression changes in response to cardiac surgery independent of outcome. Additionally, among vasoplegic patients, two marked and consistent neutrophil transcriptomic phenotypes were observed and associated with distinct clinical phenotypes. A subset of dynamic expression changes in severe vasoplegic syndrome which were not seen in surgical controls instead resembled expression in patients with septic shock with increased MMP8 mRNA. CONCLUSIONS: Dynamic gene expression in neutrophils from patients with severe vasoplegic syndrome includes both changes in response to surgery, and development of a gene expression phenotype resembling septic shock with elevated MMP8 expression. Our findings suggest a common neutrophil molecular program associated with multi-organ failure which may include common therapeutic targets for both sterile and septic systemic inflammatory states.
3. From proteomics to colloidal gold tests for urinary thrombomodulin: a prospective cohort study on accurate sepsis screening.
Urinary thrombomodulin (TM) emerged from DIA proteomics and ML feature selection as a key marker: blood TM rose with severity while urine TM fell. A urinary TM strip achieved 86% sensitivity and 78% specificity for sepsis, and urine TM thresholds predicted septic shock and 28-day mortality with AUC up to 0.92.
Impact: Presents a practical urine-based point-of-care test from discovery to validation with strong shock/mortality prediction, offering a non-invasive alternative to blood markers.
Clinical Implications: Urinary TM strips could support rapid triage and escalation decisions, complementing Sepsis-3 assessment, particularly when phlebotomy or lab turnaround delays limit timely diagnosis.
Key Findings
- Urine DIA proteomics identified 178 DEPs; ML (Boruta/Random Forest/SVM) prioritized urinary thrombomodulin.
- Blood TM increased with severity; urine TM decreased across healthy, sepsis, and septic shock groups.
- Urine TM threshold 11.85 TU/mL predicted septic shock and 28-day mortality (AUC 0.92; 93% sensitivity; 81% specificity).
- Colloidal gold urine TM strip achieved 86.1% sensitivity and 77.6% specificity versus Sepsis 3.0 criteria; performance comparable to immunofluorescence.
Methodological Strengths
- End-to-end pipeline from discovery (DIA proteomics) to validation and point-of-care strip development.
- Use of ML feature selection and multi-cohort verification including septic shock and ICU screening.
Limitations
- Single-center with modest sample sizes; external multi-ethnic validation is needed.
- Potential spectrum and incorporation biases; pre-analytical urine handling standardization required.
Future Directions: Prospective, multicenter diagnostic and prognostic validation with head-to-head comparison against established biomarkers; define clinical pathways for triage integration.
BACKGROUND: To develop a new non-invasive screening method for sepsis by detecting urine samples. METHODS: A prospective study was conducted to collect urine samples from a cohort of 22 individuals diagnosed with sepsis and admitted to the Intensive Care Unit (ICU) of a university-affiliated teaching hospital in China. Utilizing proteomic and bioinformatics analyses, we sought to identify potential biomarkers indicative of sepsis. These biomarkers were subsequently validated using serum and urine samples from 31 patients with septic shock, 83 patients with sepsis, and 50 healthy controls. Receiver operating characteristic (ROC) curves were employed to determine the optimal cutoff values for these biomarkers. Based on the diagnostic thresholds derived from ROC analysis, colloidal gold test strips were developed and applied to screen a cohort of 92 ICU patients. The diagnostic accuracy of these test strips was rigorously assessed by comparing their results with those from immunofluorescence assays. RESULTS: Data-independent acquisition (DIA) proteomics analysis of urine samples identified 2,846 proteins, with stringent filtration criteria (fold change > 2 or < 0.5, P-value < 0.05) yielding 178 differentially expressed proteins (DEPs). Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis revealed significant enrichment of DEPs in pathways associated with "cell adhesion molecules," "lysosomes," and metabolic processes. The Boruta algorithm, integrating Random Forest and Support Vector Machine (SVM) analysis, identified urinary thrombomodulin (TM) as a key candidate molecule. Immunofluorescence analysis for validation trial showed rising trend in blood TM levels across disease severities: 7.55 (6.58-8.72) TU/mL in healthy controls, 10.08 (8.00-14.15) TU/mL in general sepsis, and 12.30 (7.54-18.68) TU/mL in septic shock. Conversely, urinary TM levels decreased: 23.65 (18.08-31.06) TU/mL, 17.70 (13.80-28.80) TU/mL, and 5.84 (4.00-11.59) TU/mL, respectively. At a urinary TM threshold of 15.46 TU/mL, the ROC AUC for sepsis diagnosis is 0.72, with 57% sensitivity and 88% specificity (P<0.05), showing no significant difference comparable to blood TM (P>0.05). For septic shock diagnosis and 28-day mortality prediction, a urinary TM threshold of 11.85 TU/mL yields an ROC AUC of 0.92, with 93% sensitivity and 81% specificity, outperforming blood TM (P<0.05). A urinary TM colloidal gold test strip, which turns red at TM levels above 15.46 TU/mL, was developed and validated on urine samples from 43 sepsis and 49 non-sepsis patients, achieving 86.1% sensitivity, 77.6% specificity and an overall accuracy of 81.5% for sepsis diagnosis. The Kappa test validated the concordance of the colloidal gold strip test with Sepsis 3.0 diagnostic criteria, while the McNemar test indicated no significant difference in sepsis diagnosis efficacy between the strip test and chemiluminescent immunofluorescence (p=0.228). CONCLUSIONS: The utilization of urine test strips for the detection of TM offers a precise, convenient, and practical method for the screening of sepsis.